Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Use of DBS Cards in Diagnostic Testing
4.2.2 Rise of Forensic Toxicology Applications
4.3 Market Restraints
4.3.1 Contamination Caused in DBS Collection Cards
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Card Type
5.1.1 Ahlstrom 226
5.1.2 Whatman 903
5.1.3 FTA
5.1.4 Others
5.2 By Application
5.2.1 Infectious Disease Testing
5.2.2 Newborn Screening
5.2.3 Forensics
5.2.4 Therapeutic Drug Monitoring
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 F. Hoffmann-La Roche Ltd
6.1.2 QIAGEN
6.1.3 Shimadzu Scientific Instruments
6.1.4 Eastern Business Forms, Inc
6.1.5 Ahlstrom-Munksj?
6.1.6 PerkinElmer
6.1.7 ARCHIMEDlife
6.1.8 CENTOGENE N.V


7 MARKET OPPORTUNITIES AND FUTURE TRENDS